Form 8-K - Current report:
SEC Accession No. 0000950170-25-090493
Filing Date
2025-06-26
Accepted
2025-06-26 17:04:51
Documents
10
Period of Report
2025-06-24
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K eras-20250624.htm   iXBRL 8-K 56099
  Complete submission text file 0000950170-25-090493.txt   165268

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT eras-20250624.xsd EX-101.SCH 25793
12 EXTRACTED XBRL INSTANCE DOCUMENT eras-20250624_htm.xml XML 4879
Mailing Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121
Business Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121 (858) 465-6511
Erasca, Inc. (Filer) CIK: 0001761918 (see all company filings)

EIN.: 831217027 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40602 | Film No.: 251081200
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)